Abstract
This study aimed to compare the trace element status of patients with type 2 diabetes (n=53) with those of nondiabetic healthy controls (n=50). The concentrations of seven trace elements were determined in the whole blood, blood plasma, erythrocytes, and lymphocytes of the study subjects. Vanadium and iron levels in lymphocytes were significantly higher in diabetic patients as compared to controls (p<0.05 for iron and p<0.01 for vanadium). In contrast, lower manganese (p<0.01) and selenium (p<0.01) concentrations were detected in lymphocytes derived from patients with type 2 diabetes versus healthy subjects. Furthermore, significantly lower chromium levels (p<0.05) were found in the plasma of diabetic individuals as compared to controls. Trace element concentrations were not dependent on the degree of glucose control as determined by correlation analysis between HBA1c versus metal levels in the four blood fractions. In summary, this study primarily demonstrated that trace element levels in lymphocytes of patients with type 2 diabetes could deviate significantly from controls, whereas, in general, no considerable differences could be found when comparing the other fractions between both patient groups. Therefore, it seems reasonable to analyze metal levels in leukocytes to determine trace element status in patients with type 2 diabetes and perhaps in other diseases.
Similar content being viewed by others
References
A. D. Mooradian and J. E. Morley, Micronutrient status in diabetes mellitus, Am. J. Clin. Nutr. 45, 877–895 (1987).
J. Patrick and C. Dervish, Leukocyte zinc in the assessment of zinc status, Crit. Rev. Clin. Lab. Sci. 20, 95–114 (1984).
W. Mertz, Chromium in human nutrition: a review, J. Nutr. 123, 626–633 (1993).
P. Poucheret, S. Verma, M. D. Grynpas, and J. H. McNeill, Vanadium and diabetes, Mol. Cell. Biochem. 188, 73–80 (1998).
P. Faure, A. Roussel, C. Coudray, M. J. Richard, S. Halimi, and A. Favier, Zinc and insulin sensitivity, Biol. Trace Element Res. 32, 305–310 (1992).
J. H. McNeill, H. L. Delgatty, and M. L. Battell, Insulinlike effects of sodium selenate in streptozocin-induced diabetic rats, Diabetes 40, 1675–1678 (1991).
D. J. Becker, B. Reul, A. T. Ozcelikay, J. P. Buchet, J. C. Henquin, and S. M. Brichard, Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats, Diabetologia 39, 3–11 (1996).
J. M. Hosseini, E. Johnson, and R. J. Elin, Comparison of two separation techniques for the determination of blood mononuclear cell magnesium content, J. Am. Coll. Nutr. 2, 361–368 (1983).
K. Pomazal, C. Prohaska, I. Steffan, G. Reich, and J. F. K. Huber, Determination of Cu, Fe, Mn, and Zn in blood fractions by SEC-HPLC-ICP-AES coupling, Analyst 124, 657–663 (1999).
C. Prohaska, I. Steffan, K. Pomazal, and A. Torvenyi, Optimization of different atomic spectrometric methods for the determination of Se in blood and blood fractions, J. Anal. Atomic Spectrom. 15, 97–102 (2000).
P. Fessler, M. Rukgauer, and J. D. Kruse-Jarres, Determination of chromium in blood components of patients with diabetes mellitus type 1, Met. Ions Biol. Syst. 5, 471–475 (1998).
T. Zima, O. Mestek, V. Tesar, P. Tesarova, K. Nemecek, A. Zak, et al., Chromium levels in patients with internal diseases, Biochem. Mol. Biol. Int. 46, 365–374 (1998).
M. B. Rabinowitz, S. R. Levin, and H. C. Gonick, Comparisons of chromium status in diabetic and normal men, Metabolism 29, 355–364 (1980).
B. W. Morris, S. MacNeil, C. A. Hardisty, S. Heller, C. Burgin, and T. A. Gray, Chromium homeostasis in patients with type II (NIDDM) diabetes, J. Trace Elements Med. Biol. 13, 57–61 (1999).
R. D. Rohn, P. Pleban, and L. L. Jenkins, Magnesium, zinc and copper in plasma and blood cellular components in children with IDDM, Clin. Chim. Acta 215, 21–28 (1993).
P. Faure, P. Corticelli, M. J. Richard, J. Arnaud, C. Coudray, S. Halimi, et al., Lipid peroxidation and trace element status in diabetic ketotic patients: influence of insulin therapy, Clin. Chem. 39, 789–793 (1993).
N. R. Williams, J. Rajput-Williams, J. A. West, S. V. Nigdikar, J. W. Foote, and A. N. Howard, Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus, Analyst 120, 887–890 (1995).
R. M. Walter, Jr., J. Y. Uriu-Hare, K. L. Olin, M. H. Oster, B. D. Anawalt, J. W. Critchfield, et al., Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus, Diabetes Care 14, 1050–1056 (1991).
R. Noto, R. Alicata, L. Sfogliano, S. Neri, and M. Bifarella, A study of cupremia in a group of elderly diabetics, Acta Diabetol. Lat. 20, 81–85 (1983).
A. D. Mooradian, M. Failla, B. Hoogwerf, M. Maryniuk, and J. Wylie-Rosett, Selected vitamins and minerals in diabetes, Diabetes Care 17, 464–479 (1994).
M. D. Chen, P. Y. Lin, C. T. Tsou, J. J. Wang, and W. H. Lin, Selected metals status in patients with noninsulin-dependent diabetes mellitus, Biol. Trace Element Res. 50, 119–124 (1995).
T. Isbir, L. Tamer, A. Taylor, and M. Isbir, Zinc, copper and magnesium status in insulin-dependent diabetes, Diabetes Res. 26, 41–45 (1994).
J. T. Salonen, T. P. Tuomainen, K. Nyyssonen, H. M. Lakka, and K. Punnonen, Relation between iron stores and non-insulin dependent diabetes in men: case-control study, Br. Med. J. 317, 727 (1998).
E. S. Ford and M. E. Cogswell, Diabetes and serum ferritin concentration among U.S. adults, Diabetes Care 22, 1978–1983 (1999).
N. I. Ward and B. Pim, Trace element concentrations in blood plasma from diabetic patients and normal individuals, Biol. Trace Element Res. 6, 469–487 (1984).
N. V. Shvets, L. D. Kramarenko, S. V. Vydyborets, and S. N. Gaidukova, Disordered trace element content of the erythrocytes in diabetes mellitus, Lik. Sprava 1, 52–55 (1994).
A. Matsuda, M. Kimura, M. Kataoka, S. Ohkuma, M. Sato, and Y. Itokawa, Quantifying manganese in lymphocytes to assess manganese nutritional status, Clin. Chem. 35, 1939–1941 (1989).
C. Ruiz, A. Alegria, R. Barbera, R. Farre, and J. Lagarda, Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states, J. Trace Elements Med. Biol. 12, 91–95 (1998).
J. L. Schlienger, F. Grunenberger, E. A. Maier, C. Simon, G. Chabrier, and M. J. Leroy, Perturbation des oligoéléments plasmatiques dans le diabète. Relation avec l’équilibre glycemique, Presse Med. 17, 1076–1079 (1988).
M. Navarro-Alarcon, H. Lopez-G de la Serrana, V. Perez-Valero, and C. Lopez-Martinez, Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus, Sci. Total Environ. 228, 79–85 (1999).
M. Gebre-Medhin, U. Ewald, L. O. Plantin, and T. Tuvemo, Elevated serum selenium in diabetic children, Acta Paediatr. Scand. 73, 109–114 (1984).
A. Cser, I. Sziklai-Laszlo, H. Menzel, and I. Lombeck, Selenium status and lipoproteins in healthy and diabetic children, J. Trace Elements Electrolytes Health Dis. 7, 205–210 (1993).
E. A. Lebedeva, Relationship between serum selenium level and lipid spectrum in patients with diabetes mellitus type I, Probl. Endokrinol. (Mosk.) 37, 23–25 (1991).
W. Osterode, C. Holler, and F. Ulberth, Nutritional antioxidants, red cell membrane fluidity and blood viscosity in type 1 (insulin dependent) diabetes mellitus, Diabet. Med. 13, 1044–1050 (1996).
D. Vitoux, J. Arnaud, and P. Chappuis, Are copper, zinc and selenium in erythrocytes valuable biological indexes of nutrition and pathology? J. Trace Elements Med. Biol. 13, 113–128 (1999).
V. Badmaev, S. Prakash, and M. Majeed, Vanadium: a review of its potential role in the fight against diabetes, J. Altern. Complement. Med. 5, 273–291 (1999).
F. G. Hamel, S. S. Solomon, A. S. Jespersen, A. Blotcky, E. Rack, and W. C. Duckworth, Alteration of tissue vanadium content in diabetes, Metabolism 42, 1503–1505 (1993).
C. Terres-Martos, M. Navarro-Alarcon, F. Martin-Lagos, H. Lopez-G de la Serrana, V. Perez-Valero, and M. C. Lopez-Martinez, Serum zinc and copper concentrations and Cu/Zn ratios in patients with hepatopathies or diabetes, J. Trace Elements Med. Biol. 12, 44–49 (1998).
I. Raz and E. Havivi, Trace elements in blood cells of diabetic subjects, Diabetes Res. 10, 21–24 (1989).
N. Car, A. Car, M. Granic, Z. Skrabalo, and B. Momcilovic, Zinc and copper in the serum of diabetic patients, Biol. Trace Element Res. 32, 325–329 (1992).
L. H. Pai and A. S. Prasad, Cellular zinc in patients with diabetes mellitus, Nutr. Res. 8, 89–897 (1988).
A. Golik, N. Cohen, Y. Ramot, J. Maor, R. Moses, J. Weissgarten, et al., Type II diabetes mellitus, congestive heart failure, and zinc metabolism, Biol. Trace Element Res. 39, 171–175 (1993).
A. H. Zargar, N. A. Shah, S. R. Masoodi, B. A. Laway, F. A. Dar, A. R. Khan, et al., Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus, Postgrad. Med. J. 74, 665–668 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ekmekcioglu, C., Prohaska, C., Pomazal, K. et al. Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Elem Res 79, 205–219 (2001). https://doi.org/10.1385/BTER:79:3:205
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:79:3:205